MedTrace Logo

Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis

NCT02961634 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2017-03-31

No results posted yet for this study

Summary

Single-center study, single blind, comparative with the objective of evaluating the efficacy and safety of an investigational product as an adjunct in the treatment of onychomycosis improvement of 90 days ± 2 days.

Conditions

  • Onychomycosis

Interventions

DEVICE

Nailner 2 in 1

Nailner 2 in 1 is a combination of assets that alter the pH of the nail and is used as an adjunct in the treatment of onychomycosis.

DRUG

Ciclopirox 8%

Ciclopirox 8% is a glaze used in the treatment of onychomycosis

Sponsors & Collaborators

  • Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME

    collaborator INDUSTRY

  • MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-30
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961634 on ClinicalTrials.gov